No Data
10-Q: Mustang Bio | 10-Q: Q2 2026 Earnings Report
CAR T-Cell Therapy for Non-Hodgkin Lymphoma Market Set for Robust Growth at a CAGR of ~7% Through 2036, Driven by Expanding Indications and Clinical Adoption | DelveInsight
The CAR T-cell therapy for NHL market is witnessing rapid expansion, driven by the transition from conventional chemo-immunotherapy to advanced cell-based treatment modalities. Strong efficacy in R/
12 Health Care Stocks Moving In Friday's After-Market Session
GainersMustang Bio (NASDAQ:MBIO) shares moved upwards by 19.4% to $0.8 during Friday's after-market session. The company's market cap stands at $5.2 million. Context Therapeutics (NASDAQ:CNTX) stock
10-Q: Mustang Bio | 10-Q: Q1 2026 Earnings Report
Commission Clears Acquisition of Mustang AIV by BCI, Brookfield and NBIM
Commission Clears Acquisition of Mustang AIV by BCI, Brookfield and
10-K: Mustang Bio | 10-K: FY2025 Annual Report